Harold E Selick Protagonist Therapeutics, Inc (PTGX) insider trading activity

Harold E Selick is Director of Protagonist Therapeutics, Inc. Currently has a direct ownership of 60,845 shares of PTGX, which is worth approximately $5.15 Million. The most recent transaction as insider was on Jan 09, 2026, when has been sold 14,299 shares (Common Stock) at a price of $4.21 per share, resulting in proceeds of $60,198. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 60.8K

38.75% 3M change

83.68% 12M change

Total Value Held $5.15 Million

HAROLD E SELICK Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 09 2026	BUY Exercise of conversion of derivative security	$60,198 $4.21 p/Share	14,299 Added 19.03%	60,845 Common Stock
Jan 02 2026	BUY Grant, award, or other acquisition	-	2,695 Added 5.47%	46,546 Common Stock
Apr 28 2025	BUY Exercise of conversion of derivative security	$12,441 $1.16 p/Share	10,725 Added 19.65%	43,851 Common Stock
Jan 02 2025	BUY Grant, award, or other acquisition	-	5,130 Added 13.41%	33,126 Common Stock
Mar 07 2024	BUY Exercise of conversion of derivative security	$12,266 $1.89 p/Share	6,490 Added 18.82%	27,996 Common Stock
Apr 10 2023	BUY Exercise of conversion of derivative security	$5,390 $0.87 p/Share	6,196 Added 22.37%	21,506 Common Stock

Also insider at

MTEM

Molecular Templates, Inc. Healthcare

HES

Harold E Selick

Director

Newark, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PTGX shares.

Notify only if

Value

Insider Trading

Get notified when an Protagonist Therapeutics, Inc insider buys or sells PTGX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Protagonist Therapeutics, Inc

Track Activities on PTGX

Account